Association between left ventricular mass and telomere length in a population study

American Journal of Epidemiology

Volumn 172, Issue 4, 2010, Pages 440-450

  Kuznetsova, Tatiana ^a   Codd, Veryan ^b   Brouilette, Scott ^b   Thijs, Lutgarde ^a   González, Arantxa ^c   Jin, Yu ^a   Richart, Tom ^a,d   Van Der Harst, Pim ^e   Díez, Javier ^c   Staessen, Jan A ^a,d   Samani, Nilesh J ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF NAVARRA   (Spain)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cardiac; heart ventricles; myocytes; population; telomere

Indexed keywords

GENOMIC DNA;

APOPTOSIS; BLOOD; CARDIOVASCULAR DISEASE; DIAMETER; DRUG; GENOMICS; INDEX METHOD; MULTIVARIATE ANALYSIS; PARTICIPATORY APPROACH; POLYMERASE CHAIN REACTION; POPULATION STRUCTURE; PRESSURE EFFECT; QUANTITATIVE ANALYSIS;

ADULT; ARTICLE; CHROMOSOME SIZE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INDEX; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE WALL; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; TELOMERE; AGED; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; QUESTIONNAIRE;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; TELOMERE;

EID: 77955889201     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq142     Document Type: Article

References (39)

1. Chan SR, Blackburn EH. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci. 2004;359(1441):109-121.
2. Blasco MA. Telomeres and human disease: ageing, cancer and beyond. Nat Rev Genet. 2005;6(8):611-622.
3. Samani NJ, van der Harst P. Biological ageing and cardiovascular disease. Heart. 2008;94(5):537-539.
4. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274): 458-460.
5. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci\USA. 1992;89(21):10114-10118
6. VaziriH,DragowskaW,Allsopp RC,etal. Evidenceforamitotic clock inhuman hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci\USA. 1994;91(21):9857-9860.
7. Rota M, Hosoda T, De Angelis A, et al. The young mouse heart is composed of myocytes heterogeneous in age and function. Circ Res. 2007;101(4):387-399.
8. Chimenti C, Kajstura J, Torella D, et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res. 2003;93(7):604-613.
9. Kajstura J, Pertoldi B, Leri A, et al. Telomere shortening is an in vivo marker of myocyte replication and aging. Am J Pathol. 2000;156(3):813-819.
10. Leri A, Franco S, Zacheo A, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003;22(1):131-139.
11. Wong LS, Oeseburg H, de Boer RA, et al. Telomere biology in cardiovascular disease: the TERC-/-mouse as a model for heart failure and ageing. Cardiovasc Res. 2009;81(2):244-252.
12. Oh H, Taffet GE, Youker KA, et al. Telomerase reverse tran-scriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci\USA. 2001;98(18): 10308-10313.
13. Staessen JA, Wang JG, Brand E, et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19(8):1349-1358.
14. McArdle WD, Katch FI, Katch VL. Exercise Physiology. Energy, Nutrition, and Human Performance. Philadelphia, PA: Lea & Febiger; 1991.
15. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003; 21(6):1011-1053.
16. Kuznetsova T, Herbots L, Richart T, et al. Left ventricular strain and strain rate in a general population. Eur Heart J. 2008;29(16):2014-2023.
17. Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr. 2004;17(10):1086-1119.
18. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450-458.
19. Agabiti-Rosei E, Muiesan ML. Hypertensive left ventricular hypertrophy: pathophysiological and clinical issues. Blood Press. 2001;10(5-6):288-298.
20. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30(10):e47.
21. Brouilette SW, Moore JS, McMahon AD, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007;369(9556):107-114.
22. Kuznetsova T, Staessen JA, Thijs L, et al. Left ventricular mass in relation to genetic variation in angiotensin II receptors, re-nin system genes, and sodium excretion. European Project on Genes in Hypertension (EPOGH) Investigators. Circulation. 2004;110(17):2644-2650.
23. Vasan RS, Demissie S, Kimura M, et al. Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham Heart Study. Circulation. 2009; 120(13):1195-1202.
24. Cawthon RM, Smith KR, O'Brien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361(9355):393-395.
25. Codd V, Mangino M, van der Harst P, et al. Common variants near TERC are associated with mean telomere length. Nat Genet. 2010;42(3):197-199.
26. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763-776.
27. Gonzalez A, Rota M, Nurzynska D, et al. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res. 2008;102(5):597-606.
28. Zhang D, Gaussin V, Taffet GE, et al. TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med. 2000;6(5):556-563.
29. Cherkas LF, Hunkin JL, Kato BS, et al. The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med. 2008;168(2):154-158.
30. Nawrot TS, Staessen JA, Gardner JP, et al. Telomere length and possible link to X chromosome. Lancet. 2004;363(9408): 507-510.
31. Slagboom PE, Droog S, Boomsma DI. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet. 1994;55(5):876-882.
32. Vasa-Nicotera M, Brouilette S, Mangino M, et al. Mapping of a major locus that determines telomere length in humans. Am J Hum Genet. 2005;76(1):147-151.
33. Takubo K, Izumiyama-Shimomura N, Honma N, et al. Telo-mere lengths are characteristic in each human individual. Exp Gerontol. 2002;37(4):523-531.
34. Wilson WR, Herbert KE, Mistry Y, et al. Blood leucocyte telomere DNA content predicts vascular telomere DNA content in humans with and without vascular disease. Eur Heart J. 2008;29(21):2689-2694.
35. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol. 2007;34(4):255-262.
36. Demissie S, Levy D, Benjamin EJ, et al. Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell. 2006; 5(4):325-330.
37. Collerton J, Martin-Ruiz C, Kenny A, et al. Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85\+ Study. Eur Heart J. 2007;28(2): 172-176.
38. van der Harst P, van der Steege G, de Boer RA, et al. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol. 2007;49(13): 1459-1464.
39. Oh H, Wang SC, Prahash A, et al. Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci\USA. 2003;100(9):5378-5383.